A study evaluating 4052 oocyte donors revealed a risk of moderate to severe OHSS of < 1%, which was eliminated with the use of a GnRH antagonist protocol and GnRH agonist trigger [93]. The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.